EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Artificial Peptide-Based Bifunctional HIV-1 Entry Inhibitor That Interferes with Viral Glycoprotein-41 Six-Helix Bundle Formation and Antagonizes CCR5 on the Host Cell Membrane

Chao Wang, Qing Li, Lujia Sun, Xinling Wang, Huan Wang, Wenpeng Zhang, Jiahui Li, Yang Liu, Lu Lu iD, Shibo Jiang iD

Viruses · 2023

DOI: 10.3390/v15051038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Chao Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27 Tai-Ping Road, Beijing 100850, C…. Hauptthemen laut MEDLINE: HIV-1, HIV Fusion Inhibitors, Anti-HIV Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human immunodeficiency virus type 1 (HIV-1) is characterized by high variability and drug resistance. This has necessitated the development of antivirals with a new chemotype and therapy. We previously identified an artificial peptide with non-native protein sequence, AP3, with the potential to inhibit HIV-1 fusion through targeting hydrophobic grooves on the N-terminal heptad repeat trimer of viral glycoprotein gp41. Here, a small-molecule HIV-1 inhibitor targeting chemokine coreceptor CCR5 on the host cell was integrated into the AP3 peptide, producing a novel dual-target inhibitor with improved activity against multiple HIV-1 strains including those resistant to the currently used anti-HIV-1 drug enfuvirtide. Its superior antiviral potency in comparison with the respective pharmacophoric moieties is in consonance with the dual binding of viral gp41 and host factor CCR5. Therefore, our work provides a potent artificial peptide-based bifunctional HIV-1 entry inhibitor and highlights the multitarget-directed ligands approach in the development of novel therapeutic anti-HIV-1 agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV Fusion InhibitorsAnti-HIV AgentsHumansHIV Envelope Protein gp41PeptidesGlycoproteinsCell MembraneReceptors, CCR5

Stichwörter der Autor:innen

CCR5HIV-1coiled coilentry inhibitorsgp41multitarget-directed ligands

Substanzen

HIV Envelope Protein gp41HIV Fusion InhibitorsPeptidesAnti-HIV AgentsGlycoproteinsCCR5 protein, humanReceptors, CCR5

Autor:innen und Institutionen

  • State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27 Tai-Ping Road, Beijing 100850, China.
  • Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, 131…
  • Key Laboratory of Structure-Based Drug Design and Discovery of the Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.

ORCID-Profile: Lu Lu, Shibo Jiang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, C., Li, Q., Sun, L., Wang, X., Wang, H., Zhang, W., Li, J., Liu, Y., Lu, L., & Jiang, S. (2023). An Artificial Peptide-Based Bifunctional HIV-1 Entry Inhibitor That Interferes with Viral Glycoprotein-41 Six-Helix Bundle Formation and Antagonizes CCR5 on the Host Cell Membrane. Viruses. https://doi.org/10.3390/v15051038

Vancouver

Wang C, Li Q, Sun L, Wang X, Wang H, Zhang W, et al. An Artificial Peptide-Based Bifunctional HIV-1 Entry Inhibitor That Interferes with Viral Glycoprotein-41 Six-Helix Bundle Formation and Antagonizes CCR5 on the Host Cell Membrane. Viruses. 2023. doi:10.3390/v15051038

BibTeX
@article{Wang2023,
  author = {Wang, Chao and Li, Qing and Sun, Lujia and Wang, Xinling and Wang, Huan and Zhang, Wenpeng and Li, Jiahui and Liu, Yang and Lu, Lu and Jiang, Shibo},
  title = {An Artificial Peptide-Based Bifunctional HIV-1 Entry Inhibitor That Interferes with Viral Glycoprotein-41 Six-Helix Bundle Formation and Antagonizes CCR5 on the Host Cell Membrane},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15051038}
}
Kostenlos starten →